Evaluation Of Renal Safety Of Raas Inhibitor Therapy: A Clinical And Pharmacovigilant Study
After initiating a renin-angiotensin-aldosterone system (raas) inhibitor, there is a risk of decreased renal functions or hyperkalaemia. Hence, biochemical monitoring tests for serum creatinine and potassium are warranted after therapy initiation and are mandatory by guidelines. However, adherenc...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/62705/ http://eprints.usm.my/62705/1/24%20Pages%20from%20MOHAMMAD%20ALI%20MOHAMMAD%20KHALEEL.pdf |